Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Fatemeh Rafii, John B Sutherland & Carl E Cerniglia. (2008) Effects of treatment with antimicrobial agents on the human colonic microflora. Therapeutics and Clinical Risk Management 4:6, pages 1343-1358.
Read now
Read now
C. E. Nord & C. Edlund. (1991) Ecological Effects of Antimicrobial Agents on the Human Intestinal Microflora. Microbial Ecology in Health and Disease 4:4, pages 193-207.
Read now
Read now
Hilly G. De Vries-Hospers, Rudi H. J. Tonk & Dirk Van Der Waaij. (1991) Effect of intramuscular ceftriaxone on aerobic oral and faecal flora of 11 healthy volunteers. Scandinavian Journal of Infectious Diseases 23:5, pages 625-633.
Read now
Read now
C.E. Nord & C. Edlund. (1990) Impact of Antimicrobial Agents on Human Intestinal Microflora. Journal of Chemotherapy 2:4, pages 218-237.
Read now
Read now
Tom Bergan, Bertil Ekströn & Carl Erik Nord. (1986) Ecological Impacts of Antibacterial Agents: Stockholm, March 7–8, 1986. Scandinavian Journal of Infectious Diseases 18:sup49, pages 1-203.
Read now
Read now
Articles from other publishers (17)
C A Hobson, L Vigue, S Naimi, B Chassaing, M Magnan, S Bonacorsi, B Gachet, I El Meouche, A Birgy & O Tenaillon. (2022)
MiniBioReactor Array (MBRA)
in vitro
gut model: a reliable system to study microbiota-dependent response to antibiotic treatment
. JAC-Antimicrobial Resistance 4:4.
Crossref
Crossref
Nagisa Godefroy, Helga Junot, Laurence Drieux-Rouzet, Cyril Méloni, Charles-Edouard Luyt, Jérôme Robert & Alexandre Bleibtreu. (2021) Clostridioides difficile Infection Rates after Ceftolozane–Tazobactam and Ceftazidime–Avibactam Treatment Compared to Carbapenem Treatment: A Retrospective Single-Center Study. Hygiene 1:3, pages 99-105.
Crossref
Crossref
Hasinika K. A. H. Gamage, Carola Venturini, Sasha G. Tetu, Masrura Kabir, Vineet Nayyar, Andrew N. Ginn, Belinda Roychoudhry, Lee Thomas, Mitchell Brown, Andrew Holmes, Sally R. Partridge, Ian Seppelt, Ian T. Paulsen & Jonathan R. Iredell. (2021) Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients. Scientific Reports 11:1.
Crossref
Crossref
Petra Zimmermann & Nigel Curtis. (2019) The effect of antibiotics on the composition of the intestinal microbiota - a systematic review. Journal of Infection 79:6, pages 471-489.
Crossref
Crossref
Amira A Bhalodi, Tjitske S R van Engelen, Harjeet S Virk & W Joost Wiersinga. (2019) Impact of antimicrobial therapy on the gut microbiome. Journal of Antimicrobial Chemotherapy 74:Supplement_1, pages i6-i15.
Crossref
Crossref
Philip Toltzis, Michael Dul, Mary Ann O'Riordan, Hasida Toltzis & Jeffrey L. Blumer. (2007) Comparative Effects of Single-Dose Ceftriaxone Versus Three Oral Antibiotic Regimens on Stool Colonization by Resistant Bacilli in Children. Pediatric Infectious Disease Journal 26:1, pages 25-30.
Crossref
Crossref
Åsa Sullivan & Carl Nord. 2006. Gastrointestinal Microbiology. Gastrointestinal Microbiology
335
369
.
Åsa Sullivan, Charlotta Edlund & Carl Erik Nord. 2005. Antimicrobial Agents. Antimicrobial Agents
1357
1370
.
Harriet M. Lamb, Douglas Ormrod, Lesley J. Scott & David P. Figgitt. (2002) Ceftriaxone. Drugs 62:7, pages 1041-1089.
Crossref
Crossref
F. Vogel, H.R. Ochs, K. Wettich, S. Kaiich, I. Nihson-Ehle, I. Odenholt & C.E. Nord. (2001) Effect of step-down therapy of ceftriaxone plus loracarbef versus parenteral therapy of ceftriaxone on the intestinal microflora in patients with community-acquired pneumonia. Clinical Microbiology and Infection 7:7, pages 376-379.
Crossref
Crossref
John Manzella, Ronald Benenson, Gene Pellerin, James Kellogg, Theodore Bell, Michelle Robertson & Doris Pope. (2015)
Choice of Antibiotic and Risk of Colonization With Vancomycin-Resistant
Enterococcus
Among Patients Admitted for Treatment of Community-Acquired Pneumonia
. Infection Control & Hospital Epidemiology 21:12, pages 789-791.
Crossref
Crossref
Subhani, Kibbler & Dooley. (1999) Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Alimentary Pharmacology & Therapeutics 13:2, pages 103-116.
Crossref
Crossref
Burt R. Meyers, Patricia Wilkinson, Meryl H. Mendelson, Cynthia Bournazos, Carmelita Tejero & Shalom Z. Hirschman. (2013) Pharmacokinetics of Aztreonam in Healthy Elderly and Young Adult Volunteers. The Journal of Clinical Pharmacology 33:5, pages 470-474.
Crossref
Crossref
G. W. Welling, Geke J. Meijer-Severs, Gé Helmus, Edith van Santen, R. H. J. Tonk, Hilly G. de Vries- Hospers & D. van der Waaij. (1991) The effect of ceftriaxone on the anaerobic bacterial flora and the bacterial enzymatic activity in the intestinal tractEinfluß von Ceftriaxon auf die anaerobe Flora und die bakterielle Enzymaktivität im Intestinaltrakt. Infection 19:5, pages 313-316.
Crossref
Crossref
Thomas T. Yoshikawa. (1990) Antimicrobial Therapy for the Elderly Patient. Journal of the American Geriatrics Society 38:12, pages 1353-1372.
Crossref
Crossref
Carl Erik Nord. 1989. Anaerobic Infections in Humans. Anaerobic Infections in Humans
55
80
.
A. Rastegar Lari, J.C. Borderon, F. Gold & J. Laugier. (1989) Administration précoce d'une souche de Escherichia coli antibiosensible dans l'intestin du nouveau-né prématuré. Research in Microbiology 140:1, pages 69-73.
Crossref
Crossref